Literature DB >> 27867617

Bleeding in continuous flow left ventricular assist device recipients: an acquired vasculopathy?

Snehal R Patel1, Sasa Vukelic1, Ulrich P Jorde1.   

Abstract

Entities:  

Year:  2016        PMID： 27867617      PMCID： PMC5107551          DOI： 10.21037/jtd.2016.10.81

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  32 in total

1.  Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding.

Authors:  Corey E Tabit; Phetcharat Chen; Gene H Kim; Savitri E Fedson; Gabriel Sayer; Mitchell J Coplan; Valluvan Jeevanandam; Nir Uriel; James K Liao
Journal:  Circulation       Date:  2016-06-28       Impact factor: 29.690

2.  Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.

Authors:  Snehal R Patel; Shivank Madan; Omar Saeed; Mohammed Algodi; Anne Luke; Marc Gibber; Daniel J Goldstein; Ulrich P Jorde
Journal:  JACC Heart Fail       Date:  2016-10-12       Impact factor: 12.035

3.  Enhanced thrombin regulation during warfarin therapy in children compared to adults.

Authors:  P Massicotte; M Leaker; V Marzinotto; M Adams; R Freedom; W Williams; P Vegh; L Berry; B Shah; M Andrew
Journal:  Thromb Haemost       Date:  1998-10       Impact factor: 5.249

4.  Shear stress enhances the proteolysis of von Willebrand factor in normal plasma.

Authors:  H M Tsai; I I Sussman; R L Nagel
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

5.  Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).

Authors:  Jolanta Klovaite; Finn Gustafsson; Svend A Mortensen; Kåre Sander; Lars B Nielsen
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

Review 6.  New therapy, new challenges: The effects of long-term continuous flow left ventricular assist device on inflammation.

Authors:  Liza Grosman-Rimon; Filio Billia; Avi Fuks; Ira Jacobs; Michael A McDonald; David Z Cherney; Vivek Rao
Journal:  Int J Cardiol       Date:  2016-04-19       Impact factor: 4.164

7.  Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.

Authors:  Omar Wever-Pinzon; Craig H Selzman; Stavros G Drakos; Abdulfattah Saidi; Gregory J Stoddard; Edward M Gilbert; Mohamed Labedi; Bruce B Reid; Erin S Davis; Abdallah G Kfoury; Dean Y Li; Josef Stehlik; Feras Bader
Journal:  Circ Heart Fail       Date:  2013-03-11       Impact factor: 8.790

8.  Efficacy and safety of vorapaxar in patients with prior ischemic stroke.

Authors:  David A Morrow; Mark J Alberts; Jay P Mohr; Sebastian F Ameriso; Marc P Bonaca; Shinya Goto; Graeme J Hankey; Sabina A Murphy; Benjamin M Scirica; Eugene Braunwald
Journal:  Stroke       Date:  2013-02-08       Impact factor: 7.914

9.  Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.

Authors:  Sheri Crow; Ranjit John; Andrew Boyle; Sara Shumway; Kenneth Liao; Monica Colvin-Adams; Carol Toninato; Emil Missov; Marc Pritzker; Cindy Martin; Daniel Garry; William Thomas; Lyle Joyce
Journal:  J Thorac Cardiovasc Surg       Date:  2008-10-10       Impact factor: 5.209

10.  Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.

Authors:  Moritz Felcht; Robert Luck; Alexander Schering; Philipp Seidel; Kshitij Srivastava; Junhao Hu; Arne Bartol; Yvonne Kienast; Christiane Vettel; Elias K Loos; Simone Kutschera; Susanne Bartels; Sila Appak; Eva Besemfelder; Dorothee Terhardt; Emmanouil Chavakis; Thomas Wieland; Christian Klein; Markus Thomas; Akiyoshi Uemura; Sergij Goerdt; Hellmut G Augustin
Journal:  J Clin Invest       Date:  2012-05-15       Impact factor: 14.808
View more
  3 in total

1.  Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.

Authors:  Corey E Tabit; Mitchell J Coplan; Phetcharat Chen; Valluvan Jeevanandam; Nir Uriel; James K Liao
Journal:  J Heart Lung Transplant       Date:  2017-06-08       Impact factor: 10.247

2.  Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.

Authors:  Kenneth M Borow; Alex Yaroshinsky; Barry Greenberg; Emerson C Perin
Journal:  Circ Res       Date:  2019-07-18       Impact factor: 17.367

3.  Novel Use of Tamoxifen to Reduce Recurrent Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices.

Authors:  Michael E Plazak; Stephen J Hankinson; Erik N Sorensen; Brent N Reed; Bharath Ravichandran; Van-Khue Ton
Journal:  J Cardiovasc Transl Res       Date:  2020-11-11       Impact factor: 4.132
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.